The Impact of Tenofovir Alafenamide on Profiles of Body Weight and Metabolic Features in Chronic Hepatitis B Patients.
NCT04886336
·
clinicaltrials.gov ↗
UNKNOWN
Status
250
Enrollment
OTHER
Sponsor class
Conditions
HBV
Sponsor
National Cheng-Kung University Hospital